News

Bioengineered Protein May Prevent COVID Infections and Improve Survival  Northwestern Medicine

Study Shows Cell Membrane-Bound Enzyme is Essential for COVID-19 Infection  Northwestern Medicine

Angiotensin Therapeutics Inc. announces publication of a study using a soluble ACE2 protein designed for COVID-19  Press Release

A Novel Soluble ACE2 Protein Provides Lung and Kidney Protection in Mice Susceptible to Lethal SARS-CoV-2 Infection  Journal of the American Society of Nephrology

Can you spot the fake receptor? The coronavirus can’t either.  MIT Technology Review

Podcast: Kidneys, COVID-19 and ACE2 Connection with Daniel Batlle, MD  Northwestern University

Fooling coronavirus with new decoy protein renders it impotent   Northwestern University

Novel protein construct prevents lethal COVID-19 in mice   News Medical

Angiotensin Therapeutics Inc. Announces Publication of a Novel Approach to COVID 19 Therapy. Press Release.   

Angiotensin Therapeutics Inc. Announces Publication of a Novel Approach to COVID 19 Therapy.  BioSpace.   

New Protein Neutralizes COVID in Tiny Human Kidney.  Northwestern University.